Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Sonova AG

ClinicalTrials.gov lists Sonova AG as lead sponsor of 24 trials, counting the companies grouped under it.

CH Industry Manufacturer
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

17 0 2005 2027

Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 4 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 5 in 2026 and about 5 in 2027, the average of the 24 months through September, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored.

Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers Sonova AG and 1 company grouped under it: 24 lead-sponsored trials (0 its own, 24 in the grouped companies) and 4 legal-entity registrations (2 its own, 2 in the grouped companies).

Get the Sonova AG report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
Advanced Bionics AG 24 2

Disease areas (11)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Hearing Loss 92
Hearing Loss, Sensorineural 21
Hearing Loss, Bilateral 6
Hearing Loss, Unilateral 2
Tinnitus 2

Trials by start year as sponsor or collaborator (16)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 4
2025 5
2024 3
2023 12
2022 17
2021 14
2020 6
2019 9
2018 15
2017 4

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
50% hit target (n=38) 46% on time (n=46)

Journals published in (13)

Shown in this order: most published in first.

Journals published in
Journal Publications
The Journal of the Acoustical Society of America 6
Ear and hearing 5
Trends in hearing 5
Journal of the American Academy of Audiology 4
International journal of audiology 3

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
346 160 2025-12-09

FDA inspection record (1)

FDA inspection record
Latest classification Inspections
VAI 1

FDA import refusals (1)

FDA import refusals
Refused import lines Latest refusal
5 2025-07-07

Manufacturing and distribution sites (1)

Manufacturing and distribution sites
Facility Location Regulators Member organization
Sonova AG STAEFA Zurich, CH FDA

Organization relationships (3)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
University of Toronto Co sponsors trial with 1
Advanced Bionics (United States) Parent of 1
Advanced Bionics (United States) Ultimate parent of 1

Latest dated events (454)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-09 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-03-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-01-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-09 Patent granted Granted US patents (PatentsView / USPTO)

Biomarker capability evidence (14)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
HINT1 Trial sponsor Primary endpoint in a Phase 3 trial
SLC8A1 Trial sponsor Named in trial inclusion criteria
TFG Trial sponsor Named in trial inclusion criteria
BCHE Trial sponsor Named in trial exclusion criteria
SRF Trial sponsor Named in trial exclusion criteria

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.